Asia Now Find out what's really going on in Asia – with insights from our specialists on the ground. Filter by: Automotive & Mobility Consumer & Ecommerce Digital Media & Adtech Electronics & Embedded Software Energy & Environment General Government & NGO Industrial & Materials Intellectual Property Medtech & Life Sciences Software & Cloud Telecoms & Networks Search: Go Blog 20 July 2021 Michal Waszkiewicz'Decoding Asian Business Cultures' webinar Blog 15 July 2021 Alex GoverExpanding in Asia? Hiring is tricky and there may be a better way … Blog 14 July 2021 UK travel to East Asia infographic We’ve been looking into the restrictions on business travel to East Asia from the UK for our own team. We thought it would be useful information to share – so we’ve turned it into a simple infographic. Blog 05 July 2021 Stewart RandallRISC-V takes great leaps forward in China We’ve just attended our fourth RISC-V summit in China on behalf of our western semiconductor clients – and it’s been by far the largest and most impressive. It reflects China’s booming RISC-V ecosystem and underlines the huge and timely opportunity for international firms with the right technologies to enter the market and succeed. Blog 22 June 2021 Bio Korea 2021 – the lowdown on Korea’s thriving pharmaceutical scene Ruslan Tursunov and Sohee Yoon from our Medtech & Life Sciences team in Seoul have just been to Bio Korea 2021 - one of South Korea's busiest pharmaceutical shows. Blog 15 June 2021 Oren BernsteinDisaster management: how Japan is turning to technology This year - the 10th anniversary of Japan’s 2011 earthquake and tsunami – has not only brought back vivid memories of working in our Tokyo office that day, and what happened in the months that followed. Blog 24 May 2021 CMEF 2021 - Reporting back from China's biggest medtech expo Our Medtech & Life Sciences team has just been at CMEF 2021 in Shanghai - China's biggest medical equipment show. Blog 17 May 2021 Olexandr NykytyukThe rapid advancement of molecular diagnostics in China The last year or so has been a rollercoaster ride for the global Invitro Diagnostic (IVD) market. In early 2020, business came to an abrupt halt as hospitals and clinics closed or reduced all non-essential treatments. However, the demand for SARS-CoV-2 testing rapidly changed the sector’s dynamics and, globally, we’ve seen increasing interest – especially in molecular diagnostic (MDx) technologies. Pagination Go to page 1 Go to page 2 Go to page 3 Go to page 4 Go to page 5 Go to Next page Sign up For our news and blog posts Newsletter signup First name Surname Email Your personal data is safe with us. See our Privacy Notice.